Maarten Cozijnsen

Based on the article Anti-TNF therapy for pediatric CD: improved benefits through treatment optimisation, deeper understanding of its risks, and reduced costs due to biosimilar availability. Cozijnsen MA, Samsom JN, de Ridder L. Pediatr Drugs. 2018 Feb;20(1):19-28. General introduction Chapter 1